BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32211850)

  • 1. DNMT1 promotes cell proliferation via methylating hMLH1 and hMSH2 promoters in EGFR-mutated non-small cell lung cancer.
    Wu XY; Chen HC; Li WW; Yan JD; Lv RY
    J Biochem; 2020 Aug; 168(2):151-157. PubMed ID: 32211850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1.
    Fang JY; Lu R; Mikovits JA; Cheng ZH; Zhu HY; Chen YX
    Cancer Lett; 2006 Feb; 233(1):124-30. PubMed ID: 16473673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples.
    Wang YC; Lu YP; Tseng RC; Lin RK; Chang JW; Chen JT; Shih CM; Chen CY
    J Clin Invest; 2003 Mar; 111(6):887-95. PubMed ID: 12639995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
    Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of eukaryotic expression plasmid DNA methyltransferase gene on methylation status and transcription level of DNA mismatch repair genes in human colon cancer cell line].
    Lu R; Fang JY; Zhu HY; Chen YX; Cheng ZH; Li EL
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1014-7. PubMed ID: 15312538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas.
    Xinarianos G; Liloglou T; Prime W; Maloney P; Callaghan J; Fielding P; Gosney JR; Field JK
    Cancer Res; 2000 Aug; 60(15):4216-21. PubMed ID: 10945633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance.
    Kouso H; Yoshino I; Miura N; Takenaka T; Ohba T; Yohena T; Osoegawa A; Shoji F; Maehara Y
    J Surg Oncol; 2008 Oct; 98(5):377-83. PubMed ID: 18646042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of hMLH1 and hMSH2 immunohistochemical expression in non-small cell lung cancer. A tissue microarray study.
    Skarda J; Fridman E; Plevova P; Hajduch M; Radova L; Ofek E; Kopolovic J; Kolek V; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):255-9. PubMed ID: 17426788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch repair gene promoter methylation and expression in hydatidiform moles.
    Chen H; Ye D; Xie X; Lu W; Zhu C; Chen X
    Arch Gynecol Obstet; 2005 Jun; 272(1):35-9. PubMed ID: 15338238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer.
    Li M; Zhao ZW
    Med Oncol; 2012 Jun; 29(2):970-6. PubMed ID: 21660619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the mismatch repair gene hMLH1 is enhanced in non-small cell lung cancer with EGFR mutations.
    Li M; Zhang Q; Liu L; Lu W; Wei H; Li RW; Lu S
    PLoS One; 2013; 8(10):e78500. PubMed ID: 24205245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
    Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
    Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas.
    Vageli D; Daniil Z; Dahabreh J; Karagianni E; Vamvakopoulou DN; Ioannou MG; Scarpinato K; Vamvakopoulos NC; Gourgoulianis KI; Koukoulis GK
    Lung Cancer; 2009 Jun; 64(3):282-8. PubMed ID: 19056144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation].
    Zhu CK; Ye DF; Xie X; Cheng XD; Chen HZ; Lu WG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):422-6. PubMed ID: 12974087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.
    Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS
    J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hMSH2 and hMLH1 gene expression patterns differ between lung adenocarcinoma and squamous cell carcinoma: correlation with patient survival and response to adjuvant chemotherapy treatment.
    Vageli DP; Zaravinos A; Daniil Z; Dahabreh J; Doukas SG; Spandidos DA; Gourgoulianis KI; Koukoulis GK
    Int J Biol Markers; 2013 Jan; 27(4):e400-4. PubMed ID: 22865300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
    Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S
    Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The repression and reciprocal interaction of DNA methyltransferase 1 and specificity protein 1 contributes to the inhibition of MET expression by the combination of Chinese herbal medicine FZKA decoction and erlotinib.
    Zheng F; Zhao Y; Li X; Tang Q; Wu J; Wu W; Hann SS
    J Ethnopharmacol; 2019 Jul; 239():111928. PubMed ID: 31077779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma.
    Czerninski R; Krichevsky S; Ashhab Y; Gazit D; Patel V; Ben-Yehuda D
    Oral Dis; 2009 Apr; 15(3):206-13. PubMed ID: 19207881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation of hMLH1 correlates with the clinical response to cisplatin after a surgical resection in Non-small cell lung cancer.
    Wu F; Lu M; Qu L; Li DQ; Hu CH
    Int J Clin Exp Pathol; 2015; 8(5):5457-63. PubMed ID: 26191250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.